Merit Medical Systems, Inc.
Join Class Action »
Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Merit Medical Systems, Inc. (NASDAQ: MMSI) from February 26, 2019 through October 30, 2019 (the “Class Period”). The lawsuit seeks to recover damages for Merit Medical Systems, Inc. investors under the federal securities laws.
If you bought Merit Medical Systems, Inc. securities between February 26, 2019 through October 30, 2019, and would like to join the action, please click “Join This Class Action,” above.
SHAREHOLDER ALERT: Zhang Investor Law Announces a Securities Class Action Lawsuit Against Merit Medical Systems, Inc. – MMSI
New York, N.Y., December 8, 2019. Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Merit Medical Systems, Inc. (NASDAQ: MMSI) between February 26, 2019 and October 30, 2019, inclusive (the “Class Period”).
To join the MMSI class action, go to http://zhanginvestorlaw.com/cases/merit-medical-systems-inc/ call Sophie Zhang, Esq. toll-free at 800-991-3756 or email email@example.com for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU NEED NOT BE A LEAD PLAINTIFF IN ORDER TO OBTAIN A RECOVERY.
According to the lawsuit, throughout the Class Period (1) the integrations of Cianna and Vascular Insights, including their products, sales people, and R&D facilities, had caused operational disruptions, reduced sales, and were months behind schedule; (2) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during fiscal 2019; (3) in light of the foregoing, the Company’s reported financial guidance for fiscal 2019 and 2020 was made without a reasonable basis; and (4) as a result, Merit Medical’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 3, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://zhanginvestorlaw.com/cases/merit-medical-systems-inc/ or to discuss your rights or interests regarding this class action, please contact Sophie Zhang, Esq. of Zhang Investor Law toll free at 800-991-3756 or via e-mail at firstname.lastname@example.org.
Zhang Investor Law represents investors worldwide.